國風塑業(000859.SZ):聚酰亞胺碳基膜產品已開始進入送樣驗證階段
格隆匯 12 月 10日丨國風塑業(000859.SZ)公佈,公司高性能微電子級聚酰亞胺膜材料項目(“聚酰亞胺膜項目”)建設穩步推進,自2020年10月與桂林電器科學研究院有限公司簽訂2條國產生產線的設備採購及安裝合同後,相關項目設計工作基本完成,項目建設各項工作全面展開。
近日,公司投資建設的聚酰亞胺膜試驗線已經投入使用,公司自主研發的聚酰亞胺碳基膜產品已開始進入送樣驗證階段,該產品可用於製作高導熱石墨散熱材料,廣泛應用於5G通訊、消費電子等領域。
下一步,公司將加快推進聚酰亞胺膜項目建設,加大產品研發力度,豐富產品種類,推動聚酰亞胺膜材料產業發展。公司將根據項目進展情況持續履行信息披露義務,敬請廣大投資者注意投資風險,理性投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.